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Abstract: Bmaj-9, a basic PLA2 (13679.33 Da), was isolated from Bothrops marajoensis snake venom through 
only one chromatographic step in reversed phase HPLC on μ-Bondapak C-18 column. The amino acid 
composition showed that Bmaj-9 had a high content of Lys, His, and Arg, typical of a basic PLA2. The sequence 
of Bmaj-9 contains 124 amino acid residues with a pI value of 8.55, such as DLWQWGQMIL KETGKLPFSY 
YTAYGCYCGW GGRGGKPKAD TDRCCFVHDC, revealing a high homology with Asp49 PLA2 from other snake 
venoms. It also exhibited a pronounced phospholipase A2 activity when compared with crude venom. In 
chick biventer cervicis preparations, the time for 50% and 100% neuromuscular paralysis was respectively 
(in minutes): 110 ± 10 (1 µg/mL); 40 ± 6 and 90 ± 2 (5 µg/mL); 30 ± 3 and 70 ± 5 (10 µg/mL); 42 ± 1 and 60 
± 2 (20 µg/mL), with no effect on the contractures elicited by either exogenous ACh (110 µM) or KCl (20 
mM). Bmaj-9 (10 µg/mL) neither interfered with the muscular response to direct electrical stimulation in 
curarized preparations nor significantly altered the release of CK at 0, 15, 30 and 60 minutes incubations 
(27.4 ± 5, 74.2 ± 8, 161.0 ± 21 and 353.0 ± 47, respectively). The histological analysis showed that, even 
causing blockade at the maximum dosage (5 µg/mL), the toxin does not induce significant morphological 
alterations such as necrosis or infiltration of inflammatory cells. These results identified Bmaj-9 as a new 
member of the basic Asp49 PLA2 family able to interact with the motor nerve terminal membrane, thereby 
inducing a presynaptic neuromuscular blockade.
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INTRODUCTION
The epidemiology of snakebites in Brazil has 
shown that the genus Bothrops accounts for the 
majority of accidents (1). The high incidence 
of snakebites has been attributed to the great 
number of species (over 37), their wide geographic 
distribution and aggressiveness, as well as a highly 
efficient venomous apparatus. Studies dealing 
with the characterization of the biochemical 
composition and pharmacological actions of 
Bothrops venoms are important from the medical 
point of view and as a way to understand the 
physiopathology of envenomations. 
Undoubtedly, the study of venoms and toxins 
has been greatly facilitated by the development 
of high performance liquid chromatography 
(HPLC), automated Edman microsequencing, 
mass spectrometry and other high-end techniques 
(2).Phospholipase A2 (PLA2) is one of the most 
extensively studied family of snake venom 
proteins (3). They mostly exist as monomers. 
However, several of them interact with other PLA2 
(or PLA2-like molecules) or with other proteins 
to form complexes either through covalent or 
noncovalent interactions. Functionally, these 
PLA2 complexes exhibit presynaptic neurotoxicity 
being responsible for the major activity of 
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bothropic venoms, assembling references on the 
action and molecular structure of such toxins 
among the most cited in the scientific literature 
on animal toxinology in recent years (4, 5).
Combined with the accompanying variety 
of biophysical properties, the complexity of this 
venom makes the search and characterization 
of individual venom components a daunting 
challenge.
In vitro studies have shown that some Bothrops 
venoms and their major toxins are typically 
myotoxic in rodents; however, neurotoxic 
effects have been also revealed in mouse and 
chick. The neurotoxicity was observed by the 
blockade of neuromuscular transmission, either 
presynaptically, in a dose range similar to that of 
elapid venoms, or postsynaptically (6-14).
Both the myotoxic and neurotoxic effects of 
Bothrops venoms have been associated with their 
high PLA2 content. Secreted PLA2s (PLA2, EC 
3.1.1.4) can be small basic Ca2+-dependent proteins 
(14 to 18 kDa) usually containing 5 to 8 disulfide 
bonds and possessing a His/Asp pair required 
for catalysis (2). In addition to their possible role 
in prey digestion, snake venom PLA2s exhibit a 
wide spectrum of pharmacological effects by 
interfering with normal physiological processes. 
PLA2 effects include neurotoxic, myotoxic, 
anticoagulant and antiplatelet activities.
Bothrops marajoensis, an endemic snake from 
Marajó Island and Amazon River delta, Brazil, has 
been scarcely studied regarding the effects of its 
crude venom or its PLA2 pharmacological action 
on neuromuscular junctions (15-17). The aim of 
this study is to analyze the Bmaj-9 action on the 




Bothrops marajoensis snake venom 
was donated (lyophilized) from Batatais 
Serpentarium, Batatais, state of São Paulo, Brazil. 
All chemicals and reagents used in this research 
were of analytical or sequencing grade.
Animals
Male Hy-Line W36 chicks (4-8 days old) 
were obtained from the Globo Aves Agrovicola 
Ltd. (Brazil). The animals were kept at room 
temperature (25 ± 3°C) in a 12-hour light/dark 
cycle, with free access to food and water. All 
experiments were approved by the Institutional 
Committee for Ethics in Animal Use (CEUA/IB/
Unicamp, protocol number 1027-1) and were in 
accordance with the guidelines of the Brazilian 
Society of Laboratory Animal Science (SBCAL/
COBEA).
Isolation and Purification by Reversed Phase 
HPLC (RP-HPLC)
Ten milligrams of the whole venom of B. 
marajoensis were dissolved in 250 µL of 0.1% 
(v/v) trifluoroacetic acid (TFA, solvent A) 
and the resulting solution was clarified by 
centrifugation prior to loading the supernatant 
onto a μ-Bondapak C-18 column (0.78 cm x 30 
cm; Waters 991-PDA system, USA). Proteins 
were eluted using a linear gradient (0-100% v/v) 
of acetonitrile in 0.1% (v/v) TFA (solvent B), at a 
flow rate of 1 mL/minute. The elution profile was 
monitored at 280 nm and fractions were manually 
collected, lyophilized and stored at –20°C. The 
purified protein was referred to as Bmaj-9.
SDS-PAGE 
The fractions obtained by RP-HPLC were 
individually submitted to tricine SDS-PAGE in a 
discontinuous gel and buffer system to estimate 
the molecular mass of the Bmaj-9 PLA2 (18). 
The samples were boiled for ten minutes in a 
sample buffer containing 2.5% (m/v) SDS before 
electrophoresis. After the run, the gels were 
stained with Coomassie brilliant blue G [0.2% 
(m/v)] in methanol-acetic acid-water (4:1:6, v/v) 
and maintained in the same solution without 
dye. The molecular mass markers used were (in 
kDa): phosphorylase B (94 kDa), albumin (67 
kDa), ovalbumin (43 kDa), carbonic anhydrase 
(30 kDa), soybean trypsin inhibitor (20 kDa) 
and lysozyme (14 kDa) (Bio Agency, UK). For 
protein determination, the micro-biuret method 
by Itzhaki and Gill (19) was employed.
MALDI-TOF Mass Spectrometric Analysis 
The molecular mass of the Bmaj-9 fraction was 
determined by a Voyager-DE PRO MALDI-TOF 
mass spectrometer (Applied Biosystems, USA). 
Thus, 1 μL of Bmaj-9 in 0.1% TFA was mixed with 
2 μL of matrix sinapinic acid (3.5-dimethoxy-
4-hydroxycinnamic acid) prepared using 30% 
acetonitrile and 0.1% TFA. The equipment 
conditions were as follows: 25 kV acceleration 
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voltage, laser fixed in 2.890 μJ/com2, delay of 300 
ns and linear analysis mode (20).
Amino Acid Sequence
The amino acid sequence was conducted 
using a Pico-Tag amino acid analyzer (Waters 
Systems, USA) (21). The purified Bmaj-9 was 
hydrolyzed at 105°C for 24 hours in 6.0 M HCl 
(Pierce sequencing grade) containing 1% phenol 
(w/v). The hydrolysates were reacted with 20 
μL of derivatization solution (ethanol:triethyla
mine:water;phenylisothiocyanate, 7:1:1:1, v/v) 
for one hour, at room temperature. PTC-amino 
acids were identified and quantified by HPLC, 
comparing their retention times and peak areas 
with those from a standard amino acid mixture.
Phospholipase A2 Activity
PLA2 activity was determined at pH 8.0, which 
was adapted for 96-well plates in the present 
experiment (22-24). The standard assay mixture 
used contained 200 μL of buffer (10 mM Tris-
HCl, 10 mM CaCl2, 100 mM NaCl), 20 μL of 
substrate (4-nitro-3-octanoyloxy-benzoic acid) 
and 20 μL of water. To measure PLA2 activity, 20 
μL of Bmaj-9 was added to the mixture to achieve 
a final volume of 260 μL. After adding Bmaj-9, the 
final sample was incubated at 37°C for 40 minutes, 
and the absorbance at 425 nm was recorded at 
ten-minute intervals using a SpectraMax 340 
multiwell plate reader (Molecular Devices, USA). 
Enzyme activity, expressed as velocity of reaction 
(V), was calculated based on the increase in 
absorbance after 20 minutes. The assays were 
performed in triplicate.
Chick Biventer Cervicis Muscle Preparation 
(BC)
Male chicks (n = 6 for each Bmaj-9 
concentration) were killed with halothane, and 
their biventer cervicis muscles were removed and 
mounted under a constant tension of 1 g in a 5 mL 
organ-bath containing warmed (37°C), aerated 
(95% O2 + 5% CO2) Krebs solution [(mM, pH 
7.5): NaCl 118.7, KCl 4.7, CaCl2 1.8, KH2PO4 1.17, 
MgSO4.7H2O 1.17, glucose 11.65 and NaHCO3 
25] (25). A bipolar platinum ring electrode was 
placed around the muscle tendon, within which 
runs the motor nerve trunk supplying the muscle. 
Field stimulation was done using a Grass S48 
stimulator (Grass Instrument Co., USA) with 
0.1 Hz, 0.2 ms, 4-6 V. Muscle contractions and 
contractures were recorded isometrically via a 
force-displacement transducer (Load Cell BG – 
10GM, USA) coupled to a physiograph (Gould 
model RS 3400, USA).
The muscle responsiveness to exogenously 
applied acetylcholine (ACh, 110 µM for 60 s) and 
KCl (20 mM for 180 s) was recorded in the absence 
of field stimulation both prior to addition of toxin 
(Bmaj-9) and at the end of the experiment. The BC 
preparation was allowed stabilizing for at least 20 
minutes before addition of ACh or KCl. A range 
of Bmaj-9 concentrations (1, 5, 10 and 20 µg/mL) 
was added to the incubation bath and compared 
with control BC preparations incubated with 
Krebs solution. Experiments using 10 µg/mL 
of Bmaj-9 were done in curarized preparations 
(incubation with d-tubocurarine, d-Tc, 5 µg/mL; 
0.1 Hz, 2 ms, 8-20 V).
Creatine Kinase Activity (CK)
Aliquots of organ bath solution (50 µL) were 
collected at time 0 and after 15, 30, 60, 90 and 
120 minutes of incubation of BC with toxin (10 
µg/mL, n = 6 per time period). The samples were 
stored at 4°C and CK activity was assayed within 
4 hours after the experiment, using a commercial 
kit (CK-NAK, Bioclin, Quibasa, Química Básica 
Ltd., Brazil, batch 0107). For each aliquot 
collected, the corresponding 50 µL were replaced 
with fresh Krebs solution. CK activity was also 
assayed in control preparations without Bmaj-9. 
Enzyme activity was expressed in international 
units per liter (IU/L), with one unit of activity 
corresponding to phosphorylation of 1 µmol of 
creatine/min at 25°C.
Histopathological and Morphometric 
Analysis
The Bmaj-9 (1 and 10 µg/mL) myotoxic 
activity was assessed in biventer cervicis muscles, 
after 120 minutes of incubation, and compared 
with muscles incubated in Krebs solution for the 
same period. After, the muscles were maintained 
in Bouin’s fixative for 24 hours, washed three 
times in aqueous ammonia solution, dehydrated 
in increasing ethanol concentrations (70%, 90% 
and 3 x 100%) and embedded in historesin (Leica 
Nublock, Germany). Sections (2-μm thick) were 
obtained using a Leica RM 2035 microtome 
(Germany) and stained with toluidine blue 
for light microscopy (Olympus BX51 light 
microscope, Japan) analysis. Muscle images were 
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captured using a digital imaging system (Image 
Pro Plus 6.0, Media Cybernetics Inc., USA). Three 
non-overlapping and non-adjacent sections 
were taken from each muscle. The percentage 
of Bmaj-9 damaged muscle fibers was assessed 
by multiplying the number of injured fibers 
(vacuolated, swollen, and heavily stained fibers) 
by 100 and dividing it by the total number of 
fibers present in the whole sectional muscle area. 
The results were compared with Krebs control (n 
= 5 per treatment). Normal fibers were considered 
those with both polygonal profile and myofibers 
evenly distributed inside the fascicle.
Statistical Analysis
All data were reported as mean (± S.E.M.) of 
the number of animals used in each experiment. 
Statistical comparison of data used repeated 
measures ANOVA followed by the Tukey’s and 
Kruskal-Wallis post-hoc tests. Dunn’s multiple 
test was also performed, and all experimental 
groups were compared with control group, and p 
< 0.05 indicated statistical significance.
RESULTS
Biochemical Characterization of BMAJ-9 
The elution profile of B. marajoensis crude 
venom, after purification in one chromatographic 
step, displayed 18 peaks named according to their 
position from Bmaj-1 to Bmaj-18 (Figure 1). 
Peak 9, Bmaj-9, resulted in one small peak with 
a retention time of 36 minutes, eluting at 55% of 
solvent B. SDS-PAGE gel displayed one major 
protein band, indicating that Bmaj-9 fraction 
was obtained with high homogeneity. The Bmaj-
9 molecular mass, ~14 kDa (Figure 1), was 
confirmed by MALDI-TOF mass spectrometry 
(13.67933 Da) (Figure 2). Bmaj-9 PLA2 enzymatic 
activity was detectable in 4-nitro-3-octanoyloxy-
benzoic acid substrate, being 7.9 ± 0.5 nmol/
min/mg compared with 2.3 ± 1.1 nmol/min/mg 
for B. marajoensis crude venom, which indicated 
a high catalytic activity (Figure 3). Amino acid 
composition determined by HPLC was: Asp/8, 
Glu/9, Ser/6, Gly/13, His/2, Arg/11, Thr/8, Ala/7, 
Pro/6, Tyr/9, Val/3, Met/1, Cys/14, Ile/5, Leu/6, 
Phe/6 and Lys/10. The higher content of Lys, Hys 
and Arg residues, and the positive PLA2 activity 
characterized this fraction as a typical basic PLA2 
protein.
The N-terminal sequence of Bmaj-
9 was DLWQWGQMIL KETGKLPFSY 
YTAYGCYCGW GGRGGKPKAD 
TDRCCFVHDC… An alignment of this 
sequence with homologous snake venom PLA2 
Figure 1. RP-HPLC chromatography of B. marajoensis crude venom. The elution profile (280 nm, 55% solvent 
B; retention time of 36 minutes) displays Bmaj-9 (*) as the main fraction obtained. Insert: electrophoretic 
profile in SDS-PAGE (12.5% gel).
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Figure 2. Bmaj-9 mass (13679.33 Da) determined by MALDI-TOF mass spectrometry.
Figure 3. The graphic represents Bmaj-9 PLA2 
enzymatic activity in comparison to B. marajoensis 
crude venom, indicating a high catalytic activity of 
the toxin.
Figure 4. N-terminal amino acid sequence of Bmaj-9 compared with other Asp49 PLA2. BmjeTX-I and -II from 
B. marajoensis venom, 6-1 and 6-2 toxins from B. jararacussu venom and BmTX-I from B. moojeni venom.
from Bothrops venom is shown in Figure 4. This 
result revealed that Bmaj-9 is an Asp49 (D49).
Considering that this protein is an important 
molecule that acts by blocking the neuromuscular 
junction presynaptically, the partial sequence of 
PLA from Bothrops marajoensis snake venom in 
this study was submitted to Universal Protein 
Resource (UniProt – http://www.uniprot.org). 
The code is B3A0N3 and its similarities with the 
homologous snake venom PLA2 shown in Figure 
4 are: 92% to PLA2 BmjeTX-II, 88% to PLA2 
BmjeTX-I, 86% to PLA2 6-2, 78% to PLA2 6-1 and 
PLA2 BmjeTX-I.
Twitch Tension Recording of BC 
Bmaj-9 (1, 5, 10 and 20 µg/mL) induced an 
irreversible neuromuscular blockade in BC 
preparation, which was time/concentration-
dependent even after several washes (Figure 
5 – A). According to toxin concentration, the 
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Figure 5. (A) Neuromuscular blockade induced by crescent concentrations (1, 5, 10 and 20 µg/mL) of Bmaj-
9 in BC preparation. Note the irreversible twitch-tension neuromuscular blockade for 5, 10 and 20 µg/mL 
concentrations. (B) The graphic represents the effect on contractures to exogenous acetylcholine (ACh) 
and potassium (KCl). Each point is the mean ± S.E.M. (* p < 0.05).
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Figure 6. (A) Effect of Bmaj-9 (10 µg/mL) on curarized preparations. Note the absence of effect in the 
muscular response to direct electrical stimulation. (B) The characteristic neuromuscular blockade was not 
observed when the preparations were incubated with Bmaj-9 (10 µg/mL) at low temperature (22°C).
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time to achieve 50% neuromuscular paralysis 
after indirect electrical stimulation was: 110 ± 10 
minutes (1 µg/mL), 40 ± 6 minutes (5 µg/mL), 30 
± 3 minutes (10 µg/mL) and 42 ± 1 minutes (20 
µg/mL), whereas the time to reach 100% blockade 
was 90 ± 2 minutes (5 µg/mL), 70 ± 5 minutes (10 
µg/mL) and 60 ± 2 minutes (20 µg/mL) (n = 5 
per dose), all of them significantly different from 
control (p < 0.05).
Note that Bmaj-9 concentrations ranging from 
5 to 20 µg/mL exhibited similar blocking potency, 
indicating that, at the present experimental 
condition, 5 µg/mL represents the minimal dose 
to cause total twitch tension paralysis (Figure 5 – 
A). The contractures induced by exogenous ACh 
(110 µM) or KCl (20 mM) remained unchanged 
regardless the toxin concentration assayed 
(Figure 5 – B).
Conversely, in curarized preparations directly 
stimulated, Bmaj-9 PLA2 did not affect the muscular 
contractile response (Figure 6 – A). In addition, at 
a lower temperature (22°C), the toxin (10 µg/mL) 
did not induce the characteristic neuromuscular 
blockade seen at 37°C with the same concentration 
and time interval (Figure 6 – B).
CK Activity
Incubation with Bmaj-9 (10 µg/mL) at 0, 15, 
30 and 60 minutes did not significantly alter the 
release of CK in BC (27.4 ± 5, 74.2 ± 8, 161.0 
± 21 and 353.0 ± 47) when compared with the 
corresponding controls (37.7 ± 12, 111.5 ± 26, 
142.1 ± 23 and 248.2 ± 50). However, at 90 and 
120 minutes of toxin exposure there was a mild 
but significant increase of CK activity compared 
with control (494.7 ± 50 and 812.6 ± 95 versus 
331.0 ± 44 and 414.6 ± 67, respectively p < 0.05).
Histological Analysis
The calculation of damages caused by different 
Bmaj-9 concentrations (1, 10, 20 and 40 µg/mL, 
n = 5) of BC muscle after 120 minutes of indirect 
electrical stimulation showed the following 
negligible percentages of damaged fibers: 0.11 
± 0.1, 0.70 ± 0.6, 0.01 ± 0.01 and 3.56 ± 1.4% 
(data not shown), which did not differ from the 
Krebs solution (0.90 ± 0.41). Figure 7 shows that 
the muscle fiber morphology practically did not 
differ in the biventer cervicis muscle incubated 
with Krebs solution (Figure 7 – A) or with 1 
and 10 µg/mL of Bmaj-9 (Figures 7 – B and C, 
respectively).
Figure 7. Morphological aspects of BC muscle after 
120 minutes of incubation: (A) Krebs control, (B) 1 
µg/mL and (C) 10 µg/mL Bmaj-9. Note the preserved 
polygonal cross-sectional profile of muscle fibers in 
all treatments. No damage was detected in muscle 
fibers. Bar = 50 µm.
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DISCUSSION
Snake venom PLA2 enzymes typically exist 
in venoms as monomers and sometimes as 
complexes formed between PLA2 enzymes, as well 
as with other proteins, by covalent or noncovalent 
interactions. Snake venoms often contain many 
isoforms or isoenzymes, and therefore care must 
be taken during purification to separate them, 
as isoforms or isoenzymes may induce different 
pharmacological effects through their interaction 
with protein receptors/acceptors. This specific 
interaction with their target protein is mediated 
through specific pharmacological sites on the 
molecular surface. Upon binding to their target 
protein, they induce their effects, which may be 
dependent or independent of enzymatic activity 
(26).
One chromatographic step identified a new 
basic toxin, coined as Bmaj-9, which was shown 
to be similar to other snake venom PLA2s (20, 27-
28). Bmaj-9 amino acid composition showed a 
high content of basic and hydrophobic residues, 
with 14 half-Cys. The N-terminal amino acid 
sequence revealed a high level of homology 
among Bmaj-9 from B. marajoensis venom 
and other toxins from the same venom species, 
such as D49 PLA2s, BmjeTX-I and BmjeTX-II 
isoforms, 6-1 and 6-2 toxins from B. jararacussu 
venom and BmTX-I from B. moojeni venom (20, 
27-28). Studies on sequence homology of Bmaj-9 
showed an extremely conserved position in PLA2 
amino acids. At positions 1 and 2, amino acid 
sequence SL are prevalent; at position 4, amino 
acid Q; at positions 7-10, amino acids KMIL; at 
positions 12 and 13, amino acids ET; at position 
21, amino acid Y; at positions 25-26 and Y28, 
G30, G32, D49, H48 and Y52 are directly or 
indirectly linked in the catalysis of Bmaj-9. In 
Asp49 PLA2s there are many conserved residues 
that have important functions in the expression 
of the PLA2 activity (29).
Bmaj-9 reveals a high sequential homology 
in the N-terminal region with PLA2 from snake 
venoms displayed at positions 2 (L), 4 (Q), 8-10 
(MIL) and 12-13 (ET), except for one substitution. 
Only one difference in the N-terminal sequence 
of Bmaj-9 consisted of replacement S1 → D1, I16 
→ L16, G22 → T22, G40 → D40 and Y46 → F46. 
The amino acid differences in the N-terminal 
sequence did not decrease either the catalytic or 
the pharmacologic activity of Bmaj-9 PLA2.
Our findings showed that Bmaj-9 has potent 
neurotoxic activity, since concentrations as low 
as 1 and 5 µg/mL can lead to the blockade of the 
muscle contractile response in BC preparations. 
Bmaj-9 PLA2 neuromuscular activity was higher 
than the exhibited by the whole venom. Although 
envenomations by Bothrops snakes produce no 
neurotoxic clinical signs, venoms from several 
species can cause neuromuscular blockade in 
vitro and produce signs of peripheral muscular 
weakness in chickens and mice (7). Other PLA2 
isolated from other bothropic venoms have also 
shown neurotoxic effects (3, 17, 26, 27).
Thus, only B. jararacussu, B. insularis  and B. 
pauloensis venoms were satisfactorily investigated 
regarding this activity, including the isolation 
of neurotoxic components, all of them with 
presynaptic effects, which were mainly due to 
PLA2 (6, 30, 31). 
Bmaj-9 PLA2 from B. marajoensis venom 
induced an irreversible twitch-tension 
neuromuscular blockade at several toxin 
concentrations (1, 5, 10 or 20 µg/mL) without 
interfering with ACh and KCl induced 
contractures, hence characterizing this fraction 
as neurotoxic. In fact, even after twitch-tension 
complete paralysis (after 60 minutes of incubation 
with 10 µg/mL of Bmaj-9), neither muscle damage 
(fiber morphology, CK activity and response to 
direct stimulation) nor KCl response remained 
unchanged, hence showing absence of muscular 
effect. The findings indicate that Bmaj-9 could be 
included in the group of PLA2 neurotoxins at least 
in the present experimental conditions.
The fact that the neuromuscular effect of Bmaj-
9 was temperature-dependent suggests a role 
of the enzymatic activity in its neuromuscular 
action. In support to this view, a high catalytic 
activity was found for neuwieditoxin-I and -II 
from B. neuwiedi pauloensis venom (as per Bmaj-
9, also Asp49 PLA2s), and whose neuromuscular 
blockade also depends on the temperature (6).
All together, these results identify Bmaj-9, 
isolated from B. marajoensis venom, as a new 
member of the Asp49 PLA2 family, which acts 
by blocking the neuromuscular junction in 
presynaptic sites.
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